Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion type Assertion NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_head.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion evidence source_evidence_literature NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion SIO_000772 15709190 NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion wasDerivedFrom befree-2016 NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion wasGeneratedBy ECO_0000203 NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.